UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 368

Sortiert nach

Dendritic cells in cancer immunotherapy

European journal of immunology, 2010-08, Vol.40 (8), p.2123-2130

Schuler, Gerold

2010

Link zum Volltext

Verfügbarkeit prüfen

Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy

Immunotherapy, 2017-01, Vol.9 (2), p.115

2017

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein as an early marker of immune-related adverse events

Journal of cancer research and clinical oncology, 2019-10, Vol.145 (10), p.2625-2631

2019

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

European journal of cancer (1990), 2016-06, Vol.60, p.190-209

2016

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update

Pharmaceutics, 2020-01, Vol.12 (2), p.92

2020

Link zum Volltext

Verfügbarkeit prüfen

Senescence markers: Predictive for response to checkpoint inhibitors

International journal of cancer, 2019-03, Vol.144 (5), p.1147-1150

2019

Link zum Volltext

Verfügbarkeit prüfen

Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy

Journal of immunotherapy (1997), 2018-01, Vol.41 (1), p.35

2018

Link zum Volltext

Verfügbarkeit prüfen

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

BMC cancer, 2017-08, Vol.17 (1), p.551-551, Article 551

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance

Cancers, 2019-08, Vol.11 (8), p.1198

2019

Link zum Volltext

Verfügbarkeit prüfen

The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma

International journal of molecular sciences, 2018-08, Vol.19 (8), p.2365

2018

Link zum Volltext

Verfügbarkeit prüfen

Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells

Nature communications, 2020-10, Vol.11 (1), p.5224-5224, Article 5224

2020

Link zum Volltext

Verfügbarkeit prüfen

GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family

Frontiers in immunology, 2017-10, Vol.8, p.1388-1388

2017

Link zum Volltext

Verfügbarkeit prüfen

The use of dendritic cells in cancer immunotherapy

Current opinion in immunology, 2003-04, Vol.15 (2), p.138-147

2003

Link zum Volltext

Verfügbarkeit prüfen

CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia

International journal of molecular sciences, 2019-06, Vol.20 (11), p.2764

2019

Link zum Volltext

Verfügbarkeit prüfen

Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma

BMC cancer, 2019-03, Vol.19 (1), p.207-207, Article 207

2019

Link zum Volltext

Verfügbarkeit prüfen

The future of affordable cancer immunotherapy

Frontiers in immunology, 2023-09, Vol.14, p.1248867-1248867

2023

Link zum Volltext

Verfügbarkeit prüfen

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11951

2021

Link zum Volltext

Verfügbarkeit prüfen

Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer

Cancers, 2019-05, Vol.11 (5), p.696

2019

Link zum Volltext

Verfügbarkeit prüfen

A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma

Frontiers in immunology, 2022-02, Vol.13, p.785231-785231

2022

Link zum Volltext

Verfügbarkeit prüfen

Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone

Cancer Immunology, Immunotherapy, 2015-12, Vol.64 (12), p.1623-1635

2015

Link zum Volltext

Verfügbarkeit prüfen

A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells

International journal of molecular sciences, 2021-10, Vol.22 (19), p.10227

2021

Link zum Volltext

Verfügbarkeit prüfen

NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells

Therapeutic advances in medical oncology, 2019, Vol.11, p.1758835919891622-1758835919891622

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

Journal of cancer research and clinical oncology, 2022-04, Vol.148 (4), p.955-965

2022

Link zum Volltext

Verfügbarkeit prüfen

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy

International journal of molecular sciences, 2018-01, Vol.19 (1), p.289

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(336)
Mit Volltextzugriff
(334)

Publikationsform

Sprache

Englisch
(352)
Japanisch
(53)
Deutsch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dendritic cells in cancer immunotherapy

Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy

C-reactive protein as an early marker of immune-related adverse events

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update

Senescence markers: Predictive for response to checkpoint inhibitors

Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy

Cutaneous Na+ Storage Strengthens the Antimicrobial Barrier Function of the Skin and Boosts Macrophage-Driven Host Defense

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance

The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma

Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells

GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family

The use of dendritic cells in cancer immunotherapy

CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia

Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma

The future of affordable cancer immunotherapy

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation

Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer

A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma

Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone

A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells

NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy

Suchergebnisse filtern